(14 Aug 2020) More people in Indonesia rolled up their sleeves Friday to test a potential coronavirus vaccine developed by a Chinese company.
It was early July when the Indonesian government announced the partnership between state-owned enterprise Bio Farma and the Chinese company Sinovac BioTech.
As part of the deal, Indonesia recruited 1,620 volunteers for the trial.
The first 20 were injected in Bandung, West Java province, on Tuesday, and more followed suit.
After passing a medical and PCR (polymerase chain reaction) test to confirm their health, volunteers were given the first dose of the experimental vaccine or a placebo, then a second dose 14 days later.
Bio Farma is also planning clinical trials with thousands of volunteers in India, Brazil and Bangladesh.
The trial comes at a time when Indonesia continues to have one of the highest confirmed caseloads in the region, with the actual number of cases suspected to be much higher.
Find out more about AP Archive: [ Ссылка ]
Twitter: [ Ссылка ]
Facebook: [ Ссылка ]
Instagram: [ Ссылка ]
You can license this story through AP Archive: [ Ссылка ]
